UK markets closed

Blueprint Medicines Corporation (BPMC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
108.35+13.49 (+14.22%)
As of 03:36PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-506,984
-506,984
-557,517
-644,085
313,882
Depreciation & amortisation
11,665
11,665
11,735
6,479
6,559
Stock-based compensation
92,672
92,672
98,971
91,630
75,526
Change in working capital
-41,128
-41,128
-53,769
-23,680
-15,618
Accounts receivable
-20,715
-20,715
1,572
-18,143
-6,387
Inventory
-4,366
-4,366
-8,922
-12,561
-6,707
Accounts payable
1,880
1,880
-5,816
4,221
-791
Other working capital
-452,909
-452,909
-511,196
-559,894
383,876
Other non-cash items
24,394
24,394
-715
269,642
6,220
Net cash provided by operating activities
-436,847
-436,847
-502,277
-298,653
387,035
Cash flows from investing activities
Investments in property, plant and equipment
-16,062
-16,062
-8,919
-261,241
-3,159
Purchases of investments
-766,363
-766,363
-489,705
-655,449
-969,437
Sales/maturities of investments
1,056,465
1,056,465
349,373
690,830
538,347
Other investing activities
-
-
-290
-
-
Net cash used for investing activities
274,040
274,040
-149,541
-225,860
-434,249
Cash flows from financing activities
Debt repayment
-
-
-
-
0
Common stock issued
-
-
0
0
582,494
Other financing activities
-359
-44
415,828
-
-
Net cash used provided by (used for) financing activities
119,225
119,225
561,810
50,716
617,759
Net change in cash
-43,582
-43,582
-90,008
-473,797
570,545
Cash at beginning of period
124,904
124,904
215,119
689,804
119,604
Cash at end of period
81,524
81,524
124,904
215,119
689,804
Free cash flow
Operating cash flow
-436,847
-436,847
-502,277
-298,653
387,035
Capital expenditure
-16,062
-16,062
-8,919
-261,241
-3,159
Free cash flow
-452,909
-452,909
-511,196
-559,894
383,876